| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/12/2001 | US6245897 Monoclonal antibody recognizing cell surface antigen CD14 |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245894 Reshaped human antibody to human interleukin-8 |
| 06/12/2001 | US6245739 polypeptides and polypeptide analogues |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245734 Activate apoptosis on human pancreatic adenocarcinoma cells |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245550 Nucleotide sequence from gene homologous to erythropoetin and growth hormone; diagnosis; therapy of blood disorders, developmental/growth defects, and obesity; anti-inflammatory, antidiabetic, anticarcinogenic agents |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245540 Human choline acetyltransferase |
| 06/12/2001 | US6245536 Culturing rhodotorula using extract of soybeans or germs of soybeans as nutrient and substrate |
| 06/12/2001 | US6245531 Polynucleotide encoding insect ecdysone receptor |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245515 Double stranded dna fragment which has a p53 specific binding site and is covalently attached to insoluble polymer support |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245338 OMP26 antigen from Haemophilus influenzae |
| 06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | US6245329 Method of inducing calcium flux in cells using mammalian thymokine protein |
| 06/12/2001 | CA2173595C Dna encoding prostaglandin receptor ip |
| 06/12/2001 | CA2117477C Multivalent single chain antibodies |
| 06/12/2001 | CA2092717C Expression of g protein coupled receptors in yeast |
| 06/12/2001 | CA2060505C Method for recovering recombinant proteins |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/07/2001 | WO2001040489A1 Methods for producing a polypeptide using a consensus translational initiator sequence |
| 06/07/2001 | WO2001040476A2 Bacillus thuringiensis toxin active against formicidae (ant) |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040266A2 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 06/07/2001 | WO2001040257A2 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001020005A8 Regulatory sequences and expression cassettes for yeasts, especially for kluyveromyces |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | WO1999002187A3 Decreased fat absorption with an anti-lipase antibody |
| 06/07/2001 | DE19957904A1 Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung Insect venom allergens with reduced IgE-reactivity, and methods for their preparation |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2392946A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | CA2392906A1 Pseudomonas aeruginosa antigens |
| 06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2389262A1 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | CA2388538A1 Bacillus thuringiensis toxin active against formicidae (ant) |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/06/2001 | EP1104887A2 A method and test kit for assaying collagen fragments in body fluids |
| 06/06/2001 | EP1104809A1 Process for producing alpha-interferon |
| 06/06/2001 | EP1104808A1 ESTs and encoded human proteins |
| 06/06/2001 | EP1104807A2 Apparatus for the production of TGF-beta |
| 06/06/2001 | EP1104772A1 Antibody for detecting microorganism |
| 06/06/2001 | EP1104769A2 Modified green fluorescent proteins |
| 06/06/2001 | EP1104486A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 06/06/2001 | EP1104483A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 06/06/2001 | EP1104473A2 Proteases and associated proteins |
| 06/06/2001 | EP1104470A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/06/2001 | EP1104468A1 Genetic method for the expression of polyproteins in plants |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 06/06/2001 | EP1104455A2 Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
| 06/06/2001 | EP1104442A1 Papillomavirus cellular receptor |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP0907312A4 Compositions and methods for taxol biosynthesis |
| 06/06/2001 | EP0804457B1 Modified green fluorescenct proteins |
| 06/06/2001 | EP0706567B1 Peptide family, designated as xenonins |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | EP0579626B1 Method and agents for promoting wound healing |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298454A Process for producing protein hydrolyzate |
| 06/06/2001 | CN1298446A Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 06/06/2001 | CN1298412A G-CSF receptor agonist antibodies and screening method therefor |
| 06/06/2001 | CN1298308A Inhibitors of complement activation |
| 06/06/2001 | CN1298022A Cobra neurotoxin polypeptide strain obtained from saccharomycetes and its obtaining method |
| 06/06/2001 | CN1297941A Human CCAAT binding factor 9 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297938A Human beta tubular protein monosomic release factor 28 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297937A Mitochondrion carrier protein 14 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297936A Human guanine interconversion factor 12 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297934A Human myosin 60 as one new kind of polypeptide and polynucleotides encoding this polypeptide |